Urology · Jeffersonville, IN
NPI
1417913088
Since 2006
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
101 Hospital Blvd
Jeffersonville, IN, 47130
Phone (812) 282-3899
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.6M
29,699 services
Medicare patients, 2024
699
Average age 76
Drug cost, 2024
$27.6M
3,794 prescriptions
Company payments, 2025
$58K
From 30 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ryan J Malone was code J0897 (injection, denosumab, 1 mg), 12,780 times for 123 patients. In total Ryan J Malone billed 29,699 services in 49 codes, and Medicare paid $1.6M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-03-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 12,780 | 123 | $20.43 | $261K |
| J9155 Injection, degarelix, 1 mg | Office | 8,880 | 41 | $3.19 | $28K |
| J1952 Leuprolide injectable, camcevi, 1 mg | Office | 4,158 | 85 | $44.98 | $187K |
| 84153 Clinical Chemistry | Office | 872 | 455 | $18.02 | $16K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 843 | 465 | $11.32 | $9,540 |
| 99214 Office E&M - Established | Office | 677 | 392 | $84.07 | $57K |
| 99213 Office E&M - Established | Office | 250 | 186 | $59.18 | $15K |
| 96402 Chemotherapy Administration | Office | 216 | 142 | $24.17 | $5,221 |
| 96372 Injection Administration | Office | 159 | 123 | $9.63 | $1,531 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 150 | 45 | $45.10 | $6,765 |
| 99215 Office E&M - Established | Office | 130 | 117 | $122.30 | $16K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 72 | 12 | $141.62 | $10K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 69 | 36 | $34.68 | $2,393 |
| 36415 Venipuncture Blood Collection | Office | 49 | 48 | $8.47 | $415 |
| 82565 Clinical Chemistry | Office | 21 | 21 | $5.02 | $105 |
By year: 2022 $509K for 14,324 services; 2023 $1.3M for 32,940 services; 2024 $1.6M for 29,699 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 84153 Clinical Chemistry | 872 | 455 | $18.02 | $16K |
| 36415 Venipuncture Blood Collection | 49 | 48 | $8.47 | $415 |
| 82565 Clinical Chemistry | 21 | 21 | $5.02 | $105 |
| 81003 Clinical Chemistry | 18 | 16 | $2.20 | $39.6 |
| 84403 Clinical Chemistry | 15 | 15 | $25.29 | $379 |
Medicare prescription drug claims, 2024
In 2024, the drug Ryan J Malone prescribed most often to Medicare patients was Orgovyx (Relugolix), with 1,179 prescriptions and refills. In total Ryan J Malone wrote 3,794 Medicare prescriptions that cost $27.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Orgovyx Relugolix | 1,179 | 1,179 | 177 | $3.1M |
| Xtandi Enzalutamide | 777 | 777 | 107 | $10.5M |
| Erleada Apalutamide | 588 | 588 | 79 | $8.4M |
| Nubeqa Darolutamide | 347 | 347 | 48 | $4.6M |
| Abiraterone Acetate Generic | 263 | 263 | 42 | $866K |
| Prednisone Generic | 179 | 201 | 40 | $1,007 |
| Tamsulosin Hcl Generic | 165 | 467 | 68 | $2,328 |
| Myrbetriq Mirabegron | 37 | 69 | 11 | $31K |
| Gemtesa Vibegron | 28 | 70 | Under 11 | $34K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 26 | 66 | 11 | $351 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 25 | 25 | 11 | $56.63 |
| Finasteride Generic | 24 | 72 | 11 | $195 |
| Cephalexin Generic | 23 | 35 | Under 11 | $85.77 |
Brand drugs: 2,982 claims; generic drugs: 812 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ryan J Malone $58K ($41K in general payments such as food, travel and fees and $17K for research) from 30 companies. The largest payer was Dendreon Pharmaceuticals LLC with $32K.
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 36 | $32K |
| Janssen Biotech, Inc. JNJ | 44 | $9,674 |
| Ferring Pharmaceuticals Inc. | 10 | $4,476 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 25 | $2,337 |
| Janssen Global Services, LLC JNJ | 3 | $2,192 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $2,127 |
| Pfizer Inc. PFE | 37 | $2,038 |
| Novartis Pharmaceuticals Corporation NVS | 22 | $535 |
| Accord Healthcare, Inc. | 25 | $471 |
| Merck Sharp & Dohme LLC MRK | 14 | $447 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.